Nuclea taps Enzo to distribute metastatic breast cancer test

02/19/2014 | GenomeWeb Daily News (free registration)

Nuclea Biotechnologies has agreed to allow Enzo Clinical Labs to offer its HER-2/neu serum assay for undisclosed terms. The assay, which uses blood samples, is designed to help doctors monitor metastatic breast cancer in women whose tumors contain the HER-2/neu protein and make treatment decisions based on the outcomes.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA